RESIDUES WITHIN A CONSERVED AMINO-ACID MOTIF OF DOMAIN-1 AND DOMAIN-4 OF VCAM-1 ARE REQUIRED FOR BINDING TO VLA-4

被引:163
作者
VONDERHEIDE, RH
TEDDER, TF
SPRINGER, TA
STAUNTON, DE
机构
[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, CTR BLOOD RES, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV TUMOR IMMUNOL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
关键词
D O I
10.1083/jcb.125.1.215
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vascular cell adhesion molecule 1 (VCAM-1), a member of the Ig superfamily originally identified on activated endothelium, binds to the integrin very late antigen-4 (VLA-4), also known as alpha4beta1 or CD49d/CD29, to support cell-cell adhesion. Studies based on cell adhesion to two alternatively spliced forms of VCAM-1 or to chimeric molecules generated from them and intercellular adhesion molecule-1 (ICAM-1) have demonstrated two VLA-4 binding sites on the predominate form of VCAM-1. Here, we studied VLA-4-dependent adhesion of the lymphoid tumor cell line Ramos to cells expressing wild type and mutant forms of VCAM-1. Results based on domain deletion mutants demonstrated the existence and independence of two VLA-4-binding sites located in the first and fourth domains of VCAM-1. Results based on amino acid substitution mutants demonstrated that residues within a linear sequence of six amino acids found in both domain 1 and 4 were required for VLA-4 binding to either domain. Five of these amino acids represent a conserved motif also found in ICAM domains. We propose that integrin binding to these Ig-like domains depends on residues within this conserved motif. Specificity of integrin binding to Ig-like domains may be regulated by a set of nonconserved residues distinct from the conserved motif.
引用
收藏
页码:215 / 222
页数:8
相关论文
共 66 条
[31]  
MORALESDUCRET J, 1992, J IMMUNOL, V149, P1424
[32]  
MOULD AP, 1990, J BIOL CHEM, V265, P4020
[33]  
MOY P, 1993, J BIOL CHEM, V268, P8835
[34]   THE EXPRESSION OF ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1 (ELAM-1), INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1), AND VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1) IN EXPERIMENTAL CUTANEOUS INFLAMMATION - A COMPARISON OF ULTRAVIOLET-B ERYTHEMA AND DELAYED-HYPERSENSITIVITY [J].
NORRIS, P ;
POSTON, RN ;
THOMAS, DS ;
THORNHILL, M ;
HAWK, J ;
HASKARD, DO .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (05) :763-770
[35]  
NORTON J, 1992, BONE MARROW TRANSPL, V10, P153
[36]   VESSEL ASSOCIATED ADHESION MOLECULES IN NORMAL SKIN AND ACUTE GRAFT-VERSUS-HOST DISEASE [J].
NORTON, J ;
SLOANE, JP ;
ALSAFFAR, N ;
HASKARD, DO .
JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (07) :586-591
[37]  
NORTON J, 1992, CLIN EXP IMMUNOL, V87, P231
[38]   ACTIVATED ENDOTHELIUM BINDS LYMPHOCYTES THROUGH A NOVEL BINDING-SITE IN THE ALTERNATELY SPLICED DOMAIN OF VASCULAR CELL-ADHESION MOLECULE-1 [J].
OSBORN, L ;
VASSALLO, C ;
BENJAMIN, CD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) :99-107
[39]   DIRECT EXPRESSION CLONING OF VASCULAR CELL-ADHESION MOLECULE-1, A CYTOKINE-INDUCED ENDOTHELIAL PROTEIN THAT BINDS TO LYMPHOCYTES [J].
OSBORN, L ;
HESSION, C ;
TIZARD, R ;
VASSALLO, C ;
LUHOWSKYJ, S ;
CHIROSSO, G ;
LOBB, R .
CELL, 1989, 59 (06) :1203-1211
[40]  
PELLETIER RP, 1992, J IMMUNOL, V149, P2473